Benjamin Blasco

Global Antibiotic Research & Development Partnership

Also affiliated with Medicines for Malaria Venture

MedicineComputer ScienceImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates”.

Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00466-24

N/A

0.104DataRank · unranked

1 citations

Stephen Orena, Martin Okitwi, Patrick K. Tumwebaze, Oswald Byaruhanga, Thomas Katairo +14 more

Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials

Trends in Parasitology(2021)10.1016/j.pt.2021.04.006

N/A

0DataRank · unranked

118 citations

Benjamin Blasco, Jeremy N. Burrows, Timothy N. C. Wells, David A. Fidock, Didier Leroy +1 more

Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline

Microbiology Spectrum(2023)10.1128/spectrum.05236-22

N/A

0DataRank · unranked

10 citations

Patrick K. Tumwebaze, Martin Okitwi, Stephen Orena, Oswald Byaruhanga, Thomas Katairo +16 more